JP2021503029A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503029A5
JP2021503029A5 JP2020526569A JP2020526569A JP2021503029A5 JP 2021503029 A5 JP2021503029 A5 JP 2021503029A5 JP 2020526569 A JP2020526569 A JP 2020526569A JP 2020526569 A JP2020526569 A JP 2020526569A JP 2021503029 A5 JP2021503029 A5 JP 2021503029A5
Authority
JP
Japan
Prior art keywords
compound
donating
superbranched
hyperbranched
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020526569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021503029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061061 external-priority patent/WO2019099525A1/en
Publication of JP2021503029A publication Critical patent/JP2021503029A/ja
Publication of JP2021503029A5 publication Critical patent/JP2021503029A5/ja
Priority to JP2025023232A priority Critical patent/JP2025084800A/ja
Pending legal-status Critical Current

Links

JP2020526569A 2017-11-15 2018-11-14 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法 Pending JP2021503029A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025023232A JP2025084800A (ja) 2017-11-15 2025-02-17 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762586404P 2017-11-15 2017-11-15
US62/586,404 2017-11-15
US201862737603P 2018-09-27 2018-09-27
US62/737,603 2018-09-27
PCT/US2018/061061 WO2019099525A1 (en) 2017-11-15 2018-11-14 Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025023232A Division JP2025084800A (ja) 2017-11-15 2025-02-17 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法

Publications (2)

Publication Number Publication Date
JP2021503029A JP2021503029A (ja) 2021-02-04
JP2021503029A5 true JP2021503029A5 (https=) 2022-01-04

Family

ID=64572570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020526569A Pending JP2021503029A (ja) 2017-11-15 2018-11-14 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法
JP2025023232A Abandoned JP2025084800A (ja) 2017-11-15 2025-02-17 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025023232A Abandoned JP2025084800A (ja) 2017-11-15 2025-02-17 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法

Country Status (7)

Country Link
US (1) US12460050B2 (https=)
EP (1) EP3710514B1 (https=)
JP (2) JP2021503029A (https=)
CN (1) CN111491982B (https=)
AU (1) AU2018369760B2 (https=)
CA (1) CA3082130A1 (https=)
WO (1) WO2019099525A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018067838A1 (en) 2016-10-07 2018-04-12 The University Of North Carolina At Chapel Hill S-nitrosothiol-mediated hyperbranched polyesters
WO2018127819A1 (en) 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
JP7403152B2 (ja) 2017-03-28 2023-12-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
EP3710514B1 (en) 2017-11-15 2023-06-07 The University of North Carolina at Chapel Hill Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
CA3091458A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
CN113383019B (zh) 2018-12-28 2023-11-17 北卡罗来纳大学教堂山分校 一氧化氮释放型抗菌聚合物和由其制成的支架和其相关方法
JP7338113B2 (ja) * 2020-04-13 2023-09-05 大成建設株式会社 気体貯蔵放出化合物
WO2021257937A1 (en) * 2020-06-18 2021-12-23 Nanometics Llc (D.B.A. Phd Biosciences) Chemically cross-linked elastomers formed by michael addition and compositions comprising such elastomers
CN112023727B (zh) * 2020-08-14 2022-07-12 万华化学集团股份有限公司 一种抗污染抑菌反渗透膜、制备方法及其应用
CN114989265A (zh) * 2022-05-30 2022-09-02 浙江大学 一种具有高效广谱抗细菌、真菌功能的营养型支化结构聚多肽
CN115232318B (zh) * 2022-08-24 2023-12-26 宁波锋成先进能源材料研究院有限公司 一种非离子高分子表面活性剂及其制备方法和应用
CN118772400A (zh) * 2024-06-14 2024-10-15 华东理工大学 一种二醇二氮烯鎓超支化聚合物前驱体的制备方法
CN118955950B (zh) * 2024-07-30 2025-03-14 常熟威怡科技有限公司 一种纤维素抗菌水凝胶的制备方法和应用

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169079A (en) 1977-10-24 1979-09-25 Iwao Tabushi Polystyrene based polymers containing cyclodextrin derivatives, metal complexes of the same, and process for the production of the same
US5574027A (en) 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5234933A (en) 1991-10-31 1993-08-10 Board Of Governors Of Wayne State University And Vanderbilt University Cyclic hydroxamic acids
DE4210332C1 (https=) 1992-03-30 1993-07-15 Gruenenthal Gmbh, 5100 Aachen, De
US5814666A (en) 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5238832A (en) 1992-06-08 1993-08-24 Board Of Governors Of Wayne State University Aryl aliphatic acids
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5691423A (en) 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5650447A (en) 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5525357A (en) 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
AU685178B2 (en) 1993-10-08 1998-01-15 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
US5840759A (en) 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
ATE192922T1 (de) 1993-11-02 2000-06-15 Us Health Verwendung von stickstoffoxid freisetzenden verbindungen zur herstellung eines arzneimittels zum schutz gegen die ischämischen reperfusionsschäden
CA2205564C (en) 1994-11-22 2006-07-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
US5714511A (en) 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US20030093143A1 (en) 1999-03-01 2003-05-15 Yiju Zhao Medical device having surface depressions containing nitric oxide releasing compound
EP2292630B1 (en) 1996-09-27 2015-11-25 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
JP4285775B2 (ja) 1996-09-27 2009-06-24 アメリカ合衆国 O▲上2▼―アリール化またはo▲上2▼―グリコシル化1―置換ジアゼン―1―イウム―1,2―ジオレート類およびo▲上2▼―置換1―[(2―カルボキシラト)ピロリジン―1―イル]ジアゼン―1―イウム―1,2―ジオレート類
NO305033B1 (no) 1997-05-09 1999-03-22 Algipharma As Fremgangsmate for fremstilling av uronsyreblokker fra alginat
US6180082B1 (en) 1997-11-24 2001-01-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method to enhance tissue accumulation of radiolabeled compounds
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
JP4870314B2 (ja) 2000-05-02 2012-02-08 セラヴァンス, インコーポレーテッド シクロデキストリンを含むグリコペプチド抗生物質組成物
JP2002179647A (ja) 2000-12-11 2002-06-26 Kikkoman Corp ニコチアナミン又はニコチアナミン含有物の製造法
AUPR879601A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
DE60302454T2 (de) 2002-04-19 2006-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
US20040038947A1 (en) 2002-06-14 2004-02-26 The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services Method of treating ischemia/reperfusion injury with nitroxyl donors
US6949530B2 (en) * 2002-07-18 2005-09-27 The United States Of America As Represented By The Department Of Health And Human Services Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
NO335366B1 (no) 2002-07-26 2014-12-01 Algipharma As Mutantstamme Pf201 av Pseudomonas fluorescens og anvendelse derav i alginatproduksjon,samt fremgangsmåte for fremstilling derav.
NO20023581D0 (no) 2002-07-26 2002-07-26 Fmc Biopolymer As Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
BRPI0314042B8 (pt) 2002-09-06 2021-05-25 Calando Pharmaceuticals Inc polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
US20050009789A1 (en) 2003-05-13 2005-01-13 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service Cyclooxygenase inhibition with nitroxyl
JP2005047979A (ja) 2003-07-30 2005-02-24 Dainippon Ink & Chem Inc 多分岐ポリマーの製造方法、及び多分岐ポリマー
SG113562A1 (en) 2004-01-12 2005-08-29 Agency Science Tech & Res Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
US20050265958A1 (en) * 2004-05-14 2005-12-01 West Jennifer L Nitric oxide releasing compositions and associated methods
US8097343B2 (en) * 2004-08-31 2012-01-17 Triton Systems, Inc. Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
CN101151037A (zh) 2005-01-28 2008-03-26 平纳克尔医药股份有限公司 作为抗菌剂的β-环糊精衍生物
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
AU2014221249B2 (en) * 2005-05-27 2016-05-05 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
WO2007053292A2 (en) 2005-10-31 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
JP2009523584A (ja) 2006-01-24 2009-06-25 ミリメッド・アクティーゼルスカブ Ph依存性薬物放出を有する医療デバイス
US7854923B2 (en) 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
CN101049513B (zh) 2007-05-13 2010-05-19 刘万顺 水溶性壳聚糖基纤维止血愈创材料及其制备方法和应用
ITMI20071341A1 (it) 2007-07-05 2009-01-06 Fidia Farmaceutici Derivati di acido ialuronico contenenti gruppi in grado di rilasciare no
EP2209472A1 (en) 2007-10-12 2010-07-28 The University of North Carolina at Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
HUE034051T2 (en) 2007-11-27 2018-01-29 Algipharma As Use of alginate-containing oligomers to combat biofilms
US20090222088A1 (en) 2008-02-29 2009-09-03 Medtronic Vascular, Inc. Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
US20090232863A1 (en) 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
EP2260060A4 (en) 2008-04-01 2013-01-16 Univ Cornell ORGANIC SOLUBLE CHITOSA SALT AND CHITOSAN DERIVED BIOMATERIALS MANUFACTURED THEREFROM
CN102256989B (zh) 2008-10-03 2016-01-06 聚糖生物科学有限责任公司 糖基化细菌代谢物的阴离子轭合物
EP2398761A4 (en) 2009-02-18 2015-11-04 Bezwada Biomedical Llc CONTROLLED RELEASE OF NITRIC OXIDE AND MEDICINES FROM FUNCTIONALIZED MACROMERS AND OLIGOMERS
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US20120107229A1 (en) 2009-04-15 2012-05-03 Xuefei Huang Novel nano-probes for molecular imaging and targeted therapy of diseases
US9539233B2 (en) 2009-05-04 2017-01-10 Aridis Pharmaceuticals Inc. Gallium formulation for the treatment and prevention of infectious diseases
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
ES2444541T3 (es) 2009-06-03 2014-02-25 Algipharma As Oligómeros de alginato para usar para superar la multirresistencia a fármacos en bacterias
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
US9957341B2 (en) 2009-06-09 2018-05-01 William Chambers Biodegradable absorbent material and method of manufacture
WO2010147831A1 (en) * 2009-06-15 2010-12-23 Wayne State University Dendrimer based nanodevices for therapeutic and imaging purposes
CA2671595A1 (en) 2009-07-09 2011-01-09 Ping I. Lee Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes
US8551456B2 (en) 2010-03-05 2013-10-08 University Of Dayton Combination therapy and methods for treating bacterial biofilms
EP2547660B1 (en) 2010-03-19 2015-01-07 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
KR101272351B1 (ko) 2010-04-23 2013-06-07 이화여자대학교 산학협력단 새로운 카나마이신 화합물, 카나마이신 생산 스트렙토마이세스 속 미생물 및 카나마이신의 생산 방법
KR101255337B1 (ko) 2010-10-04 2013-04-16 한국과학기술연구원 온도 감응성 합성 고분자를 이용한 일산화질소 전달체
US9034355B2 (en) 2011-02-24 2015-05-19 Colorado State University Research Foundation Materials for modulating biological responses and methods of making
WO2013029009A1 (en) 2011-08-24 2013-02-28 Novan, Inc. Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
US9017653B2 (en) 2012-06-14 2015-04-28 The Board Of Regents Of The University Of Texas System Nitric oxide-releasing compositions and methods
CN106986952B (zh) 2012-08-17 2020-03-10 北卡罗来纳大学查珀尔希尔分校 水溶性的释放一氧化氮的聚葡糖胺和其用途
WO2014138425A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Cyclosporine a-steroid conjugates
GB201322777D0 (en) 2013-12-20 2014-02-05 Algipharma As Use of alginate oligomers as blood anticoagulants
JP2017501221A (ja) 2013-12-23 2017-01-12 ノルウェージャン ユニバーシティ オブ サイエンス アンド テクノロジー(エヌティーエヌユー) がん治療におけるオリゴウロン酸塩の使用
RU2016136449A (ru) 2014-02-28 2018-04-02 АльгиФарма АС Применение олигометов альгината в лечении муковисцидоза и других состояний, ассоциированных с нарушенной функцией ионных каналов cftr
GB201415381D0 (en) 2014-08-29 2014-10-15 Algipharma As Inhalable powder formulations of alginate oligomers
WO2016073835A1 (en) 2014-11-06 2016-05-12 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
US11170451B2 (en) 2015-10-02 2021-11-09 Not So Forgetful, LLC Apparatus and method for providing gift recommendations and social engagement reminders, storing personal information, and facilitating gift and social engagement recommendations for calendar-based social engagements through an interconnected social network
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
CN106046382B (zh) * 2016-05-25 2018-10-09 暨南大学 一种装载一氧化氮的阳离子聚合物及其制备方法和应用
WO2018067838A1 (en) 2016-10-07 2018-04-12 The University Of North Carolina At Chapel Hill S-nitrosothiol-mediated hyperbranched polyesters
WO2018127819A1 (en) 2017-01-03 2018-07-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
JP7403152B2 (ja) * 2017-03-28 2023-12-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
EP3710514B1 (en) 2017-11-15 2023-06-07 The University of North Carolina at Chapel Hill Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
CA3091458A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
US11102301B2 (en) 2018-07-12 2021-08-24 Sap Se PCA-based scoring of the similarity of damage patterns of operational assets
CN113383019B (zh) 2018-12-28 2023-11-17 北卡罗来纳大学教堂山分校 一氧化氮释放型抗菌聚合物和由其制成的支架和其相关方法

Similar Documents

Publication Publication Date Title
JP2021503029A5 (https=)
Nadagouda et al. Antimicrobial activity of quaternary ammonium salts: structure-activity relationship
Fugolin et al. Antibacterial, ester-free monomers: Polymerization kinetics, mechanical properties, biocompatibility and anti-biofilm activity
CN101511335B (zh) 包含对头发具有牢固性的聚合物的头发处理组合物
JP2013542992A5 (https=)
HRP20190876T1 (hr) Novi adjuvantirani pripravci
Huang et al. Antibacterial effect of a resin incorporating a novel polymerizable quaternary ammonium salt MAE‐DB against Streptococcus mutans
JP2021502395A5 (https=)
AR010560A1 (es) Compuestos derivados de nonoato donantes de oxido nitrico; composiciones farmaceuticas que los contienen; metodo para la dilatacion local de los vasossanguineos de mamiferos y metodo para matar o inactivar bacterias en la boca de un mamifero
JP2020515688A5 (https=)
Manouchehri et al. Synthesis and characterization of novel polymerizable bis-quaternary ammonium dimethacrylate monomers with antibacterial activity as an efficient adhesive system for dental restoration
MX2010008468A (es) Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante.
AR048596A1 (es) Atenuacion sinergica del virus de estomatitis vesiculosa, sus vectores y sus composiciones inmunogenas
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
Huang et al. Physical and chemical properties of an antimicrobial Bis-GMA free dental resin with quaternary ammonium dimethacrylate monomer
DE602004028151D1 (de) Härtbare silikonzusammensetzung und gehärtetes produkt daraus
CL2008003202A1 (es) Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
JP2007302651A (ja) イミダゾリウム塩を有する光硬化性単量体、それを含有する抗菌性光硬化型組成物、及びその組成物から製造される抗菌性高分子材料
Wang et al. Yeast β-glucan promotes antiviral type I interferon response via dectin-1
Homayoon et al. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice
Weng et al. Synthesis and evaluation of a novel antibacterial dental resin composite with quaternary ammonium salts
RU2013135887A (ru) Композиции для комплекса респираторных заболеваний собак
RU2018137897A (ru) Пути улучшения лечения рака
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
JP2025111445A5 (https=)